Article Information
History
- September 21, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Radha Rajasingham, MD1,†,
- Ananta S Bangdiwala, MS1,
- Melanie R Nicol, PharmD, PhD1,
- Caleb P Skipper, MD1,
- Katelyn A Pastick, BSc1,
- Margaret L Axelrod, BSc2,
- Matthew F Pullen, MD1,
- Alanna A Nascene, BA1,
- Darlisha A Williams, MPH1,
- Nicole W Engen, MS1,
- Elizabeth C Okafor, BSc1,
- Brian I Rini, MD2,
- Ingrid A Mayer, MD2,
- Emily G McDonald, MD3,
- Todd C. Lee, MD, MPH3,
- Peter Li, MD4,
- Lauren J MacKenzie, MD MPH5,
- Justin M Balko, PharmD, PhD2,
- Stephen J Dunlop, MD MPH1,6,
- Katherine H Hullsiek, PhD1,
- David R Boulware, MD MPH1,*,‡,
- Sarah M Lofgren, MD1,* and
- on behalf of the COVID PREP team
- 1University of Minnesota, Minneapolis, Minnesota
- 2Vanderbilt University Medical Center, Nashville, Tennessee
- 3Research Institute of the McGill University Health Centre and the Clinical Practice Assessment Unit, Department of Medicine, McGill University, Montreal
- 4Oregon Health & Science University, Portland, OR
- 5Section of Infectious Diseases, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba
- 6Hennepin Healthcare, Minneapolis, Minnesota
- ↵†Corresponding Author: Radha Rajasingham, 689 23rd Ave SE, Minneapolis, MN 55455, radha{at}umn.edu
- ↵‡Alternate corresponding author: David Boulware, 689 23rd Ave SE, Minneapolis, MN 55455, Boulw001{at}umn.edu
↵* equal contribution
Posted September 21, 2020.
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
